These medications have been approved by regulatory authorities specifically for obesity treatment and have shown significant weight loss benefits in clinical trials
Semaglutide is a GLP-1 receptor agonist primarily used as a treatment for diabetes (Ozempic, Novo Nordisk) and more recently greenlit as a breakthrough treatment for obesity (Wegovy, Novo Nordisk)
What is not fully resolved from Zevay's public materials: which exact legal entity credentials the reviewing providers beneath "Telegra MD," which compounding framework its pharmacy partners operate under, whether insurance applies, current LegitScript certification status, and a live pricing conflict - three different starting prices ($149, $187, and $199 per month) appear across Zevay's own pages depending on which one you land on
Regardless of Wegovy storage practices, serious side effects such as hypoglycemia, gallbladder issues, pancreatitis, and thyroid problems should be reported to a healthcare professional immediately
Request a fresh vial, ideally from a recently compounded batch, and verify storage conditions